Page 11 - ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Highlights WHO has approved vaccines Pfizer-BioNTech, AstraZeneca- SK Bio/SII, Johnson & Johnson Janssen, Moderna, and Sinopharm for emergency use The trial was conducted on 25,800 subjects, and the data submitted to the Subject Expert Committee (SEC) showed the vaccine was “well-tolerated” Hyderabad: The Hyderabad-based Bharat Biotech on Monday (July 13) said it expects to receive emergency use listing (EUL) from the global body at the earliest. “All documents required for emergency use listing (EUL) of Covaxin have been submitted to WHO as of July 9. The review process has now commenced with the expectation that we will receive EUL from the WHO at the earliest,” said Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech.

Andhra pradeshJohnson janssenKrishna ellaExpert committeeHyderabad based bharat biotechManaging directorSubject expert committeeஆந்திரா பிரதேஷ்ஜான்சன் ஜான்சன்கிருஷ்ணா எல்லாநிபுணர் குழுஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்நிர்வகித்தல் இயக்குனர்பொருள் நிபுணர் குழு